Form 4: Ventyx Biosciences Executive Acquires Shares Through Employee Stock Purchase Plan

Roy Gonzales, Senior VP of Finance at Ventyx Biosciences, reports the acquisition of 1,750 shares of common stock through the company's Employee Stock Purchase Plan at a price of $1.03 per share.

Summary

• Roy Gonzales, Senior VP of Finance at Ventyx Biosciences, filed a Form 4 detailing changes in beneficial ownership.
• The report indicates the acquisition of 1,750 shares of Ventyx Biosciences common stock on May 15, 2025, through the company's 2021 Employee Stock Purchase Plan (ESPP).
• The shares were purchased at a price of $1.03 per share, based on 85% of the closing price on May 15, 2025, as per the ESPP terms.
• Following the reported transaction, Gonzales directly owns 3,546 shares of Ventyx Biosciences common stock, which includes 1,053 shares acquired on November 15, 2024, through the ESPP.

Sentiment

Score: 6

Explanation: Neutral sentiment. The filing simply reports a routine transaction related to an employee stock purchase plan. It doesn't inherently indicate positive or negative news about the company's performance.

Positives

• The acquisition of shares by a company executive can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure related to insider transactions and is common for publicly traded companies. It provides transparency into the trading activities of company executives.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals insider confidence.

Key Dates

Keywords

Ventyx Biosciences, VTYX, Form 4, Beneficial Ownership, Employee Stock Purchase Plan, ESPP, Roy Gonzales, Insider Trading